Involvement of the sigma1 receptor in the antidepressant-like effects of fluvoxamine in the forced swimming test in comparison with the effects elicited by paroxetine

European Journal of Pharmacology

Volumn 696, Issue 1-3, 2012, Pages 96-100

  Sugimoto, Yumi ^a   Tagawa, Noriko ^b   Kobayashi, Yoshiharu ^b   Mitsui Saito, Kumiko ^c   Hotta, Yoshihiro ^c   Yamada, Jun ^a  

^a YOKOHAMA COLLEGE OF PHARMACY   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^c KINJO GAKUIN UNIVERSITY   (Japan)

Author keywords

Fluvoxamine; Forced swimming test; Paroxetine; Sigma1 receptor; SSRI (Selective serotonin reuptake inhibitor)

Indexed keywords

FLUVOXAMINE; N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; N ALLYLNORMETAZOCINE; PAROXETINE; SEROTONIN TRANSPORTER; SIGMA 1 OPIATE RECEPTOR; ANTIDEPRESSANT AGENT; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ANTIIMMOBILITY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANIMAL BEHAVIOR; COMPARATIVE STUDY; DBA MOUSE; MOTOR ACTIVITY; PHYSIOLOGY; SWIMMING;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR, ANIMAL; FLUVOXAMINE; MALE; MICE; MICE, INBRED DBA; MOTOR ACTIVITY; PAROXETINE; RECEPTORS, SIGMA; SWIMMING;

EID: 84869085739     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.09.030     Document Type: Article

References (32)

1. Y. Ago, K. Yano, N. Hiramatsu, K. Takuma, and T. Matsuda Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both 5-HT reuptake inhibition and sigma(1) receptor activation Psychopharmacology 217 2011 377 386
2. J.E. Bermack, and G. Debonnel The role of sigma receptors in depression J. Pharmacol. Sci. 97 2005 317 336 (Pubitemid 40515745)
3. 1A ligand: modulation of neuronal activity in the dorsal raphe nucleus J. Pharmacol. Exp. Ther. 310 2004 578 583 (Pubitemid 38988902)
4. L. Cervo, A. Canetta, E. Calcagno, S. Burbassi, G. Sacchetti, S. Caccia, C. Fracasso, D. Albani, G. Forloni, and R.W. Invernizzi Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression J. Neurosci. 25 2005 8165 8172 (Pubitemid 41292111)
5. D. David, C. Renard, P. Jolliet, M. Hascoet, and M. Bourin Antidepressant-like effects in various mice strains in the forced swimming test Psychopharmacology 66 2003 373 382 (Pubitemid 36503032)
6. N. Egashira, S. Harada, R. Okuno, M. Matsushita, R. Nishimura, K. Mishima, K. Iwasaki, K. Orito, and M. Fujiwara Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine Eur. J. Pharmacol. 563 2007 149 154 (Pubitemid 46602243)
7. D. Figgitt, and K. McClellan Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders Drugs 60 2000 925 954
8. T. Harasawa, Y. Ago, S. Itoh, A. Baba, and T. Matsuda Role of serotonin type 1A receptors in fluvoxamine-induced inhibition of marble-burying behavior in mice Behav. Pharmacol. 17 2006 637 640 (Pubitemid 44526741)
9. K. Hashimoto, Y. Fujita, and M. Iyo Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors Neuropsychopharmacology 32 2007 514 521
10. T. Hayashi, T. Maurice, and T.P. Su Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration J. Pharmacol. Exp. Ther. 293 2000 788 798 (Pubitemid 30417843)
11. Y. Ichimaru, T. Egawa, and A. Sawa 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice Jpn. J. Pharmacol. 68 1995 65 70
12. L.H. Jacobson, and J.F. Cryan Feeling strained? Influence of genetic background on depression-related behavior in mice: a review Behav. Genet. 37 2007 171 213 (Pubitemid 46150858)
13. G. Lucas, V.V. Rymar, A.F. Sadikot, and G. Debonnel Further evidence for an antidepressant potential of the selective sigma1 agonist SA 4503: electrophysiological, morphological and behavioural studies Int. J. Neuropsychopharmacol. 11 2008 485 495 (Pubitemid 351744813)
14. G. Lucas, V.V. Rymar, A.F. Sadikot, and G. Debonnel Further evidence for an antidepressant potential of the selective sigma1 agonist SA 4503: electrophysiological, morphological and behavioural studies Int. J. Neuropsychopharmacol. 11 2008 485 495 (Pubitemid 351744813)
15. I. Lucki, A. Dalvi, and A.J. Mayorga Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice Psychopharmacology 155 2001 315 322 (Pubitemid 32477289)
16. T. Maurice, A. Urani, V.L. Phan, and P. Romieu The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities Brain Res. Rev. 37 2001 116 132 (Pubitemid 34020726)
17. N. Narita, K. Hashimoto, S. Tomitaka, and Y. Minabe Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain Eur. J. Pharmacol. 307 1996 117 119 (Pubitemid 26226293)
18. V. Perez, D. Puiigdemont, I. Gilaberte, E. Alvarez, and F. Artigas Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors J. Clin. Psychopharmacol. 21 2001 36 45 (Pubitemid 32096748)
19. B. Petit-Demouliere, F. Chenu, and M. Bourin Forced swimming test in mice: a review of antidepressant activity Psychopharmacology 177 2005 245 255 (Pubitemid 40137284)
20. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioural despair in mice: a primary screening test for antidepressants Arch. Int. Pharmacodyn. 229 1977 327 336 (Pubitemid 8225714)
21. D.S. Reddy, G. Kaur, and S.K. Kulkarni Sigma (sigma1) receptor mediated antidepressant-like effects of neurosteroids in the Porsolt forced swim test Neuroreport 9 1998 3069 3073 (Pubitemid 28555648)
22. V. Sabino, P. Cottone, S.L. Parylak, L. Steardo, and E.P. Zorrilla Sigma-1 receptor knockout mice display a depressive-like phenotype Behav. Brain Res. 198 2009 472 476
23. C. Sanchez, and J. Hyttel Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding Cell. Mol. Neurobiol. 19 1999 467 489 (Pubitemid 29283825)
24. 2 receptor antagonist reduces immobility of mice treated with the atypical antidepressant mianserin in the forced swimming test Biol. Pharm. Bull. 25 2002 1479 1481 (Pubitemid 39663170)
25. Y. Sugimoto, Y. Kajiwara, K. Hirano, S. Yamada, N. Tagawa, Y. Kobayashi, Y. Hotta, and J. Yamada Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding Eur. J. Pharmacol. 592 2008 116 122
26. 1A receptor binding Eur. J. Pharmacol. 629 2010 53 57
27. Y. Sugimoto, M. Yamamoto, N. Tagawa, Y. Kobayashi, K. Mitsui-Saitoh, Y. Hotta, and J. Yamada Differences between mice strains in response to paroxetine in the forced swimming test: involvement of serotonergic or noradrenergic systems Eur. J. Pharmacol. 672 2011 121 125
28. A. Urani, F.J. Roman, V.L. Phan, T.P. Su, and T. Maurice The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test J. Pharmacol. Exp. Ther. 298 2001 1269 1279 (Pubitemid 32761949)
29. V. Villard, J. Meunier, N. Chevallier, and T. Maurice Pharmacological interaction with the sigma1 (sigma1)-receptor in the acute behavioral effects of antidepressants J. Pharmacol. Sci. 115 2011 279 292
30. A. Wagstaff, S. Cheer, A. Matheson, D. Ormrod, and K. Goa Paroxetine: an update of its use in psychiatric disorders in adults Drugs 62 2002 655 703 (Pubitemid 34264033)
31. O.M. Wolkowitz, V.I. Reus, E. Roberts, F. Manfredi, T. Chan, W.J. Raum, S. Ormiston, R. Johnson, J. Canick, L. Brizendine, and H. Weingartner Dehydroepiandrosterone (DHEA) treatment of depression Biol. Psychiatry 41 1997 311 318 (Pubitemid 27095256)
32. 2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test Brain Res. 958 2002 161 165 (Pubitemid 35441224)